NCT03231358CompletedPhase 3
Our Family Our Future: A Resilience-oriented Family Intervention to Prevent Adolescent HIV/STI Infection and Depression in South Africa
Source: ClinicalTrials.gov · Last updated 15 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of this study is to test the efficacy of Our Family Our Future, an integrated intervention for preventing HIV and depression onset among adolescents.
- Status (registry)
- Completed
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 1758 (actual)
- First submitted
- 21 Jul 2017
- Start date
- 21 Nov 2018
- Primary completion date
- 31 Aug 2022
- Lead sponsor
- Brown University
- Diseases
- HIV
- NCT number
- NCT03231358
What you commit to
- Study type: Interventional · Phase 3
- Participants enrolled: 1758
- From 21 Nov 2018 to the primary completion date, 31 Aug 2022
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- no or low symptoms (\<6) or clinically significant thresholds of depression (16+)
Who the study is looking for
- 14-16 years
- adolescent concurs that the adult identified is their parent (to also include primary caregivers in the pa-rental role)
- when more than one child in the family falls within the eligible age range, one child will be chosen at random
- lives in the household at least 4 days a week
Age in the registry: 14 years to 16 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Masiphumelele Coordinator of this site? Confirm its status | Cape Town | South Africa | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.